Climate Change Data Portal
DOI | 10.3390/molecules27010313 |
Plant Secondary Metabolites Produced in Response to Abiotic Stresses Has Potential Application in Pharmaceutical Product Development | |
Yeshi, Karma; Crayn, Darren; Ritmejeryte, Edita; Wangchuk, Phurpa | |
发表日期 | 2022 |
EISSN | 1420-3049 |
卷号 | 27期号:1 |
英文摘要 | Plant secondary metabolites (PSMs) are vital for human health and constitute the skeletal framework of many pharmaceutical drugs. Indeed, more than 25% of the existing drugs belong to PSMs. One of the continuing challenges for drug discovery and pharmaceutical industries is gaining access to natural products, including medicinal plants. This bottleneck is heightened for endangered species prohibited for large sample collection, even if they show biological hits. While cultivating the pharmaceutically interesting plant species may be a solution, it is not always possible to grow the organism outside its natural habitat. Plants affected by abiotic stress present a potential alternative source for drug discovery. In order to overcome abiotic environmental stressors, plants may mount a defense response by producing a diversity of PSMs to avoid cells and tissue damage. Plants either synthesize new chemicals or increase the concentration (in most instances) of existing chemicals, including the prominent bioactive lead compounds morphine, camptothecin, catharanthine, epicatechin-3-gallate (EGCG), quercetin, resveratrol, and kaempferol. Most PSMs produced under various abiotic stress conditions are plant defense chemicals and are functionally anti-inflammatory and antioxidative. The major PSM groups are terpenoids, followed by alkaloids and phenolic compounds. We have searched the literature on plants affected by abiotic stress (primarily studied in the simulated growth conditions) and their PSMs (including pharmacological activities) from PubMed, Scopus, MEDLINE Ovid, Google Scholar, Databases, and journal websites. We used search keywords: stress-affected plants, plant secondary metabolites, abiotic stress, climatic influence, pharmacological activities, bioactive compounds, drug discovery, and medicinal plants and retrieved published literature between 1973 to 2021. This review provides an overview of variation in bioactive phytochemical production in plants under various abiotic stress and their potential in the biodiscovery of therapeutic drugs. We excluded studies on the effects of biotic stress on PSMs. |
英文关键词 | secondary metabolites; climate change; drug discovery; abiotic stress |
语种 | 英语 |
WOS研究方向 | Biochemistry & Molecular Biology ; Chemistry, Multidisciplinary |
WOS类目 | Science Citation Index Expanded (SCI-EXPANDED) |
WOS记录号 | WOS:000741135500001 |
来源期刊 | MOLECULES
![]() |
文献类型 | 期刊论文 |
条目标识符 | http://gcip.llas.ac.cn/handle/2XKMVOVA/281087 |
作者单位 | James Cook University; James Cook University |
推荐引用方式 GB/T 7714 | Yeshi, Karma,Crayn, Darren,Ritmejeryte, Edita,et al. Plant Secondary Metabolites Produced in Response to Abiotic Stresses Has Potential Application in Pharmaceutical Product Development[J],2022,27(1). |
APA | Yeshi, Karma,Crayn, Darren,Ritmejeryte, Edita,&Wangchuk, Phurpa.(2022).Plant Secondary Metabolites Produced in Response to Abiotic Stresses Has Potential Application in Pharmaceutical Product Development.MOLECULES,27(1). |
MLA | Yeshi, Karma,et al."Plant Secondary Metabolites Produced in Response to Abiotic Stresses Has Potential Application in Pharmaceutical Product Development".MOLECULES 27.1(2022). |
条目包含的文件 | 条目无相关文件。 |
除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。